Medical Therapy. Efficacy or Lack of Efficacy

The Road to Heart Transplant in a Patient With Cardiomyopathy, Shone Complex, and Severe Pulmonary Hypertension

Arif Albulushi, Shabib Al-Asmi, Moosa Al-Abri, Hatem Al-FarhanUniversity of Nebraska Medical Center. Royal Hospital. Heart Hospital, Armed Forces Hospital and Sultan Qaboos University Hospital. Hamad Medical Corporation. United States, Oman and Qatar Journal of the American College of Cardiology Case ReportsJACC Case Rep 2024; 29:DOI: 10.1016/j.jaccas.2024.102323 AbstractOur case report details the journey of a 16-year-old male […]

The Road to Heart Transplant in a Patient With Cardiomyopathy, Shone Complex, and Severe Pulmonary Hypertension Read More »

Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study

Konstantin E. Belozerov, Natalia M. Solomatina, Eugenia A. Isupova, Alla A. Kuznetsiva, Mikhail M. KostikSaint-Petersburg State Pediatric Medical University. Children’s City Polyclinic No. 29 of the Kalininsky District of St. Petersburg. Almazov National Medical Research Centre.Russia World Journal of Clinical PediatricsWorld J Clin Pediar 2024; 13:DOI: 10.5409/wjcp.v13.i1.88912 AbstractBackground: Lung damage in systemic juvenile arthritis (sJIA) is one

Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study Read More »

Tadalafil in Neonates and Infants With Pulmonary Hypertension Secondary to Bronchopulmonary Dysplasia

Amy Kiskaddon, Tanaka Dang, Daniel MaurielloJohns Hopkins All Children’s Hospital. Johns Hopkins University School of Medicine. Texas Children’s Hospital.United States Journal of Pediatric Pharmacology and TherapeuticsJ Pediatr Pharmacol Ther 2024; 29: 140-143DOI: 10.5863/1551-6776-29.2.140 AbstractObjectives: The primary outcome of this study was to describe the dosing regimen of tadalafil in neonates and infants diagnosed with pulmonary hypertension (PH)

Tadalafil in Neonates and Infants With Pulmonary Hypertension Secondary to Bronchopulmonary Dysplasia Read More »

Low global arginine bioavailability: a common phenomenon in pulmonary hypertension

Dunia Hatabah, Teresa De Marco, Dana P. McGlothlin, Mary Malloy, Loretta Z. Reyes, Rawan Korman, Gregory J. Kato, Claudia R. MorrisEmory University School of Medicine. University of California, San Francisco. Kaiser Permanente San Francisco. Children’s Healthcare of Atlanta. Blood Science Consulting.United States American Journal of Physiology Lung Cellular and Molecular PhysiologyAm J Physiol Lung Cell

Low global arginine bioavailability: a common phenomenon in pulmonary hypertension Read More »

The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension

David Langleben, Stylianos E. Orfanos, Benjamin D. Fox, Nathan Messas, Michele Giovinazzo, John D. CatravasJewish General Hospital and McGill University. Evangelismos Hospital and National and Kapodistrian University of Athens Medical School. Yitzchak Shamir Hospital and Tel Aviv University. Old Dominion University.Canada, Greece, Israel and United States Journal of Clinical MedicineJ Clin Med 2022; 11:DOI: 10.3390/jcm11154568 AbstractExercise-induced

The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension Read More »

Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis

Shajie Ur Rehman Usmani, Syed Umar Hasan, Syed Hasan Ali, Syeda Hoorulain Ahmed, Neha Pervez, Muhammad Danial, Owais Khan, Dominique L. Tucker, M. Mujeeb ZubairDow University of Health Sciences. Case Western Reserve University. Cedars-Sinai Hospital.Pakistan and United States Asian Journal of SurgeryAsian J Surg 2024; DOI: 10.1016/j.asjsur.2024.03.003 AbstractTo provide an updated meta-analysis to evaluate the efficacy

Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis Read More »

Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure

Dana R. Tower, Ronald W. Day, Tighe Marrone, Rachel Palmquist, Lincoln D. Nadauld, Joshua L. Bonkowsky, Sabrina Malone JenkinsUniversity of Utah School of Medicine and Primary Children’s Hospital. Intermountain Precision Genomics. United States Cold Spring Harbor Molecular Case StudiesCold Spring Harb Mol Case Stud 2024; 9:DOI: 10.1101/mcs.a006292 AbstractAlveolar capillary dysplasia (ACD) is a fatal disorder that

Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure Read More »

Improving Outcomes in Pulmonary Vein Stenosis: Novel Pursuits and Paradigm Shifts

Rachel D. VanderlaanHospital for Sick Children.Canada Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery AnnualSeminThorac Cardiovasc Surg Pediatr Card Surg Annu 2024; 27: 92-99DOI: 10.1053/j.pcsu.2024.01.003 AbstractPulmonary vein stenosis (PVS) remains a clinical challenge, with progressive restenosis being common. In the past five years, we have seen an exponential increase in both clinical and scientific publication

Improving Outcomes in Pulmonary Vein Stenosis: Novel Pursuits and Paradigm Shifts Read More »

Acute Lung Edema as a Presentation of Severe Acute Reentry High-Altitude Illness in a Pediatric Patient

Alfredo Merino-Luna, Julio Vizcarra-AnayaSan Pablo Clinic Huaraz. Universidad Peruana de Ciencias Aplicadas.Peru Case Reports in PediatricsCase Rep Pediatr 2020;DOI: 10.1155/2020/8871098 AbstractAcute high-altitude pulmonary edema (HAPE) is a pathology involving multifactorial triggers that are associated with ascents to altitudes over 2,500 meters above sea level (m). Here, we report two pediatric cases of reentry HAPE, from the

Acute Lung Edema as a Presentation of Severe Acute Reentry High-Altitude Illness in a Pediatric Patient Read More »

High-altitude Illnesses and Air Travel: Pediatric Considerations

Nelson Villca, Adriana Asturizaga, Alexandra Heath-FreudenthalHospital Materno Infantil. Hospital de la Banca Privada. Kardiozentrum.Bolivia Pediatric Clinics of North AmericaPediatr Clin North Am 2021; 68: 305-319 DOI: 10.1016/j.pcl.2020.09.015 AbstractHealthy children may present acute mountain sickness (AMS) within a few hours after arrival at high altitudes. In few cases, serious complications may occur, including high-altitude pulmonary edema and rarely

High-altitude Illnesses and Air Travel: Pediatric Considerations Read More »

Scroll to Top